Infectious Complications in Cancer Patients

While advances in both the treatment of cancer and the management of its complications have led to significant improvement in patient survival, infections remain a significant cause of morbidity and mortality in patients with neoplastic disease. In this patient population, infection risk results fro...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Stosor, Valentina. (Editor, http://id.loc.gov/vocabulary/relators/edt), Zembower, Teresa R. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2014.
Edition:1st ed. 2014.
Series:Cancer Treatment and Research, 161
Subjects:
Online Access:https://doi.org/10.1007/978-3-319-04220-6
LEADER 04278nam a22005295i 4500
001 978-3-319-04220-6
003 DE-He213
005 20210617014232.0
007 cr nn 008mamaa
008 140405s2014 gw | s |||| 0|eng d
020 |a 9783319042206  |9 978-3-319-04220-6 
024 7 |a 10.1007/978-3-319-04220-6  |2 doi 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Infectious Complications in Cancer Patients  |h [electronic resource] /  |c edited by Valentina Stosor, Teresa R. Zembower. 
250 |a 1st ed. 2014. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2014. 
300 |a X, 511 p. 18 illus., 13 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Cancer Treatment and Research,  |x 0927-3042 ;  |v 161 
505 0 |a Host impairments in patients with neo plastic diseases -- Epidemiology of Infections in Cancer Patients -- Bacterial Pathogens -- Fungal Infections in Cancer Patients -- Advances in the Management of Viral Infections -- Neutropenic Fever and Sepsis: Evaluation and Management -- Respiratory Infections -- Enteric Infections -- Central Nervous System Infections in Cancer Patients and Hematopoietic Stem Cell Transplant Recipients -- Dermatologic infections in cancer patients.- Infections in Patients with Leukemia and Lymphoma -- Infectious Complications of Stem Cell Transplantation -- Infections Associated with Solid Malignancies -- Antimicrobial Agents, Drug Adverse Reactions and Interactions and the Cancer Population -- Infection Control and Prevention Considerations -- Prevention of Infection in Cancer Patients. 
520 |a While advances in both the treatment of cancer and the management of its complications have led to significant improvement in patient survival, infections remain a significant cause of morbidity and mortality in patients with neoplastic disease. In this patient population, infection risk results from a complex interplay between the host’s underlying immunodeficiencies, local tumor effects, and treatment-induced immunosuppression. New chemotherapeutic approaches and antimicrobial prophylaxis and treatment practices continue to shape the spectrum of infections in these patients. Clinicians who treat infections in cancer patients are continually challenged by the emergence of new pathogens and by the increasing antimicrobial resistance of established ones.   The aim of this book, is to emphasize unique aspects of management of infectious diseases in the cancer patient. With the increasing complexity of this patient population, optimal management requires a multidisciplinary approach, and this fact is fully reflected in the contributions, all from recognized authorities in the field. Ultimately, it is hoped that this volume will assist specialists in infectious diseases and haematology/oncology in the diagnosis, management, and prevention of infection and optimization of the overall care of patients with malignancies. 
650 0 |a Oncology  . 
650 0 |a Infectious diseases. 
650 0 |a Hematology. 
650 1 4 |a Oncology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33160 
650 2 4 |a Infectious Diseases.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33096 
650 2 4 |a Hematology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H3307X 
700 1 |a Stosor, Valentina.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Zembower, Teresa R.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319042190 
776 0 8 |i Printed edition:  |z 9783319042213 
776 0 8 |i Printed edition:  |z 9783319380643 
830 0 |a Cancer Treatment and Research,  |x 0927-3042 ;  |v 161 
856 4 0 |u https://doi.org/10.1007/978-3-319-04220-6 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)